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a b s t r a c t
In the last years, neurological complications related to Zika virus (ZIKV) infection have emerged as an
important threat to public health worldwide. ZIKV infection has been associated to neurological disor-
ders such as congenital microcephaly in newborns and Guillain-Barre syndrome, myelopathy and en-
cephalitis in adults. ZIKV is characterized by neurotropism and neurovirulence. Several studies have
identiﬁed microglial nodules, gliosis, neuronal and glial cells degeneration and necrosis in the brain of
ZIKV infected infants, suggesting that ZIKV could play a role in these neurological disorders through
neuroinﬂammation and microglial activation.
Little information is available about neuroinﬂammation and ZIKV-related neurological disorders.
Therefore, we investigated if ZIKV is able to infect a glial cell line (U87-MG) and how the glial cell line
responds to this infection in terms of inﬂammation (IL-1b, NLRP-3 and CASP-1), oxidative stress (SOD2
and HemeOX) and cell death.
We observed a signiﬁcant increase of ZIKV load in both cells and supernatants after 72 h, compared to
48 h of infection. We found that ZIKV infection induces an increase of IL-1b, NLRP-3 and CASP-1 genes
expression. Signiﬁcant increase of IL-1b and unchanged pro-IL-1b protein levels have also been detected.
Moreover, we observed SOD2 and HemeOX increased gene expression mainly after 72 h post ZIKV
infection. Subsequently, we found a decrease of U87-MG cell viability, after both 48 h and 72 h of ZIKV
infection.
Our results show that U87-MG cells are susceptible to ZIKV infection. ZIKV is able to successfully
replicate in infected cells causing oxidative stress, NLRP3 inﬂammasome activation and subsequent
release of mature IL-1b; this process culminates in cell death. Thus, considering the central role of
neuroinﬂammation in neurological disorders, it is important to comprehend every aspect of this
mechanism in order to better understand the pathogenesis of ZIKV infection and to identify possible
strategies to ﬁght the virus by rescuing cell death.
1. Introduction
The rapid spread of Zika virus (ZIKV) and its association with
congenital brain defects are considered an important threat to
public health worldwide. ZIKV is an emerging Arbovirus belonging
to the Flaviviridae family and Flavivirus genus, which includes,
among others, Dengue, West Nile, Yellow Fever and Japanese en-
cephalitis viruses. Like other members of this genus, ZIKV has a
positive-sense, single-stranded RNA genome [1].
ZIKV infection was reported sporadically in different regions of
Africa, as well as in some countries in Asia; in the Yap Islands, an
island chain in the Federated States of Micronesia, had represented
the ﬁrst major outbreak of Zika virus. Subsequently, ZIKV has been
identiﬁed in French Polynesia, Easter Island (Chile), the Cook
Islands, New Caledonia and more recently in Central and South
America [2,3].
Phylogenetic analyses disclose two important lineages, African
and Asian, originating from a single ancestor. The African lineage
has never been associated with congenital malformations or
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2neurological complications, as observed for the Asian lineage. The
Asian lineage has been involved in the epidemics in the Paciﬁc
Islands and more recently in Brazil, South and Central Americas
[4,5].
The clinical manifestations are usually not speciﬁc and charac-
terized by fever, maculopapular rash, headache, conjunctivitis,
myalgia, and arthralgia. Major complications include neurological
disorders such as congenital microcephaly in newborns and Guil-
lain-Barre syndrome (GBS), myelopathy and encephalitis in adults
[1,6].
Mother to-child transmission of ZIKV, occurring in utero or
perinatally, has already been described. The association between
this infection during pregnancy and foetal malformations was
determined after the increase in microcephaly cases in newborns in
the northeastern region of Brazil in 2015, during ZIKV outbreak
[7,8].
To date, several types of foetal malformations have been
described as associated with ZIKV intrauterine infection, currently
referred to as congenital ZIKV syndrome (CZS), which includes not
only microcephaly and foetal brain damage, but also a number of
abnormalities of the musculoskeletal development, ocular, cranio-
facial, genitourinary and intrauterine growth retardation [9,10].
Several studies have shown the presence of viral RNA and an-
tigen in the brain, but not in other organs, of congenitally infected
foetuses and newborns [6,9,11]. In fact, ZIKV targets neural pro-
genitor cells, leading to damage and consequent loss of these cells
as well as reduced generation of new neurons in these regions [12].
Autopsy and pathological examination of the brain of infants with
microcephaly, who had died less than 24 h after birth, revealed
microglial nodules, gliosis, cellular degeneration and necrosis that
preferentially targeted neuronal and glial cells [6,13].
The ZIKV entry into a host cell is mediated by the viral envelope
protein, which interacts with several cell surface receptors and
attachment factors. Nowakowski TJ and collaborators identiﬁed
AXL as a possible candidate ZIKV entry receptor, highly expressed in
central nervous system (CNS) cells such as microglial cells, astro-
cytes and radial glial cells [14].
ZIKV induces an innate antiviral response in mammalian cells,
such as primary human skin ﬁbroblasts, producing type I in-
terferons in infected cells [15,16]. Furthermore, markers associated
with oxidative stress responses have been observed in patients with
severe Dengue virus infection. Olagnier and collaborators have
demonstrated a relationship between oxidative stress and viral
pathogenesis using human dendritic cells (DC), the primary target
of DENV infection; actually, oxidative stress triggers innate antiviral
immune responses and induces apoptosis [17]. Flavivirus replica-
tion may result in oxidative stress that in turn might induce the
inﬂammasome activation. NLRP3 is the best-known Nod-like re-
ceptor (NLR) associated with inﬂammasome activation. NLRP3
activation is also correlated to oxidative stress, being oxidative
stress observed upon treatment with many NLRP3 activators
[18,19]. Chen and collaborators reported that HCV RNA, in human
myeloid cells, activates the NLRP3 inﬂammasome in a ROS-
dependent manner, conﬁrming the close relationship between
oxidative stress and inﬂammasome activation [20]. NLRP3 a cyto-
solic multiprotein complex, through the activation of pro-caspase-1,
induces proteolysis and release of pro-inﬂammatory cytokines, such
as IL-1b; this release could prompt pyroptotic cell death [21,22]. Wu
and collaborators observed NLRP3 inﬂammasome activation and IL-
1b release inmacrophages infectedwith Dengue virus. These events
lead ultimately to cell death via pyroptosis [23]. Several studies
reported NLRP3 inﬂammasome activation and IL-1b release during
infection of ﬂaviviruses associated to CNS damage [24,25].
To date little information regarding ZIKV, inﬂammasome acti-
vation and inﬂammation especially in CNS are available. For these
reasons we decided to investigate if ZIKV is able to infect the U87-
MG glial cell line and to study how U87-MG responds to this
infection in terms of inﬂammation (IL-1b, inﬂammasome NLRP3
and CASP1), oxidative stress (SOD2 and HemeOX) and cell death.
2. Materials and methods
2.1. Cell culture and ZIKV infection
U87-MG cells (human glioblastoma cell line), generously pro-
vided by Prof. Del Sal G. (University of Trieste, Italy) were cultured
in Minimum Essential Medium Eagle (MEME, Sigma, Italy), sup-
plemented with 10% fetal bovine serum (FBS, Euroclone, Italy),
4 mM glutamine and 2 mM penicillin streptomycin anphotericin B
1  solution (Sigma, St. Louis, MO) and used between passages 4 to
10 to avoid cellular senescence.
ZIKV, MRS ZKV CTA 723 strain has been kindly provided by the
Italian Istituto Superiore di Sanita. U87-MG were seeded in 6-well
or 96 multi-well plate and after 24 h were infected at MOI 4.5 and
incubated 24 h at 37 C and 5% CO2. After 24 h the medium was
removed and cells were washed once with PBS. Culture medium
was added to each well, and cells were incubated at 37 C and 5%
CO2 for further 24 h and 48 h.
2.2. Detection of ZIKV
Culture supernatants and cells collected 48 h and 72 h post
infection. Nucleic acids were extracted from supernatants and cells
with QIAamp Viral RNA Mini Spin Kit (Qiagen) according to the
manufacturer's protocol and were eluted in 70 mL. ZIKV RNA was
detected by a qualitative real-time RT-PCR, amplifying a 76-
nucleotide segment of the envelope gene, as described by Lan-
ciotti et al. [26] (Tab. 1). The ampliﬁcation were carried out in a
7300 Real-time PCR System (Applied Biosystems, Thermo Fisher
Scientiﬁc) by using SuperScript® III One-Step RT-PCR System with
Platinum® Taq DNA Polymerase kit (Invitrogen, Life Technologies).
We performed ZIKV quantiﬁcation using the Zika MR766molecular
standard, kindly provided by the Robert Koch Institute (Berlin,
Germany).
2.3. RNA isolation and real time-PCR
Total RNA was reverse transcribed into cDNA with a High Ca-
pacity cDNA Reverse Transcription Kit with RNase Inhibitor
(Applied Biosystems®, Monza, Italy). Semi-quantitative real-time
PCR was performed using Taqman Gene Expression Assays for
human ACTB (Hs99999903_m1), IL-1b (Hs01555410_m1), NLRP3
(Hs00366465_m1), CASP1 (Hs00354836_m1), SOD2
(Hs00167309_m1) and HemeOH (Hs01110250_m1) genes (Applied
Biosystems® Thermo Fisher, Monza, Italy) with the ABI 7500 Fast
Real-Time PCR platform (Applied Biosystems® Thermo Fisher,
Monza, Italy). The PCR ampliﬁcation cycle was “standard mode”:
after denaturation at 96 C for 10 min, 40 PCR cycles were per-
formed composed by 15 s at 95 C and a ﬁnal melting step for
1min at 60 C. All samples were analysed in triplicate using the SDS
1.4 software (Applied Biosystems® Thermo Fisher, Monza, Italy).
Results were normalized to ACTB expression and then to untreated
cells according to 2DDCt method [27].
2.4. Western blot
U87-MG cells were lysed in RIPA buffer (10 mM Tris-HCl pH 8.0,
1 mM EDTA, 1% Triton X-100, 140 mM NaCl). Cellular lysates were
quantiﬁed using Bradford assay (Biorad, Hercules, USA); equal
amounts of protein were loaded on 4e20% Tris-Tricine gels and
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3transferred on nitrocellulose membrane (Biorad, Hercules, USA).
Membranes were then incubated with primary antibodies and then
developed with HRP-conjugated secondary antibodies and
Clarity™ substrate (Biorad Hercules, USA). Primary antibodies used
in this study were: anti- IL-1b (Abcam, UK), and -HSP-90 (Santa-
Cruz, Dallas, USA). Relative quantiﬁcation of pro-IL-1b and IL-1b
was normalized to HSP-90 optical density.
2.5. MTT cell viability assay
Cell viability was determined by a colorimetric assay using 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) cell proliferation assay (Trevigen, Gaithersburg, MD).
Absorbance was measured in GloMax®-Multi Detection System
(Promega, Fitchburg, WI).
2.6. Data analysis
Statistical signiﬁcance was calculated using paired t-test or one-
way analysis of variance (ANOVA) and Bonferroni post-test
correction in case of multiple comparisons. Analysis was per-
formed using GraphPad Prism software (version 5.0).
3. Results
3.1. ZIKV replicates in U87-MG
In order to assess infectivity of ZIKV in U87-MG cells, the
quantiﬁcation of ZIKV in supernatants and U87-MG cells exposed to
ZIKV was evaluated 48 and 72 h after the infection.
The ZIKV load increased both in U87-MG cells and in superna-
tant; in fact, intracellular ZIKV load augmented signiﬁcantly after
72 h of infection compared to the viral load in cells after 48 h of
infection (ZIVK load copies/mL: ZIKV 72 h 6.21 � 109±1.73 � 109,
p ¼ 0.006.; ZIKV 48 h 5.52 � 108±6.5 � 108) (Fig. 1a). Also in su-
pernatant ZIKV load was signiﬁcantly higher after 72 h of infection
than after 48 h of infection (Fig. 1b) (ZIVK load copies/mL: ZIKV 72 h
2.78� 106±5.62� 105, p¼ 0.0024; ZIKV 48 h 5.3� 105±8.35� 104)
(Fig. 1b).
3.2. IL-1b and NLRP3 inﬂammasome activation after ZIKV infection
The ZIKV induction of inﬂammation associated to NLRP3
inﬂammasome activation and subsequent IL-1b production in U87-
MG was investigated. In addition to IL-1b, also the gene expression
of NLRP-3 and CASP-1, the main components of the inﬂammasome,
was investigated.
We observed a 2.07 ± 0.25 fold IL-1b expression after 48 h and a
further signiﬁcant increase of 3.62 ± 1.75 times after 72 h compared
to the control cells (NT) (p ¼ 0.04) (Fig. 2a).
ZIKV in U87-MG induced an increase of 3.86 ± 1.07 and
3.17 ± 1.63 times for NLRP3 (Fig. 2b) and of 2.93 ± 0.86 and
3.11 ± 1.87 for CASP-1 (Fig. 2c) after 48 and 72 h respectively when
compared to untreated condition; however the increase was not
statistically signiﬁcant.
To double-check the IL-1b gene expression results, we also
measured IL-1b protein levels through western blot analysis. We
conﬁrmed the same trend observed when analysing IL-1b expres-
sion: ZIKV caused after 72 h a signiﬁcant increase of IL-1b protein
levels with a relative quantiﬁcation of 0.57 ± 0.5 fold and
1.76 ± 0.01 fold increase in infected vs uninfected cells after 48 and
72 h, respectively (72 h p ¼ 0.02) (Fig. 2d). Instead, pro-IL-1b pro-
tein levels did not vary, conﬁrming that the majority of the pro-IL-
1b protein produced is cleaved in IL-1b active form (pro-IL-1b
relative quantiﬁcation in ZIKV infected cells was 0.79 ± 0.47 after
48 h and 1.00 ± 0.27 after 72 h when compared to control cells)
(Fig. 2e).
3.3. Oxidative stress after ZIKV infection
In order to verify whether inﬂammasome NRLP3 activation is
connected to oxidative stress, we evaluated the gene expression of
SOD2 and HemeOX, two important markers of oxidative stress.
ZIKV infection in U87-MG induces oxidative stress, especially
after 72 h. We observed a 4.29 ± 0.87 fold increase of SOD2
expression after 48 h and further 5.21 ± 3.53 fold increase after 72 h
when compared to untreated condition, however the increase was
not statistically signiﬁcant (Fig. 3a). The HemeOX expression
increased of 3.02 ± 1.06 times after 48 h and then signiﬁcantly
augmented 4.42 ± 1.72 times after 72 h of ZIKV infection, when
compared to control cells (p ¼ 0.03) (Fig. 3b).
3.4. ZIKV alters U87-MG cell viability
Considering the important inﬂammatory effect of ZIKV in U87-
MG, we evaluated this effect on cell viability. A signiﬁcant
decrease of cell viability in ZIKV infected cells was observed, both
after 48 and 72 h, when compared to untreated condition (% Sur-
vival: ZIKV 48 h 84.11 ± 2.33, p ¼ 0.0003; ZIKV 72 h 76.68 ± 5.46,
p ¼ 0.00001; NT 100) (Fig. 4).
Fig. 1. ZIKV has been quantiﬁed in U87-MG cells and supernatants. U87-MG cells were infected with ZIKV for 48 and 72 h. At the end of the incubation periods we separated and
collected supernatants and cells. ZIKV RNAwas semi-quantitatively detected by a real time quantitative polymerase chain reaction (PCR), amplifying a 76-nucleotide segment of the
envelope gene, according to Lanciotti et al. (2008). ZIKV load copies/mL was performed using Zika virus PCR-standard (a) in U87-MG cells and (b) in supernatant. Results are
representative of three independent experiments. Data analyses were performed with paired t-test comparing 48 h with 72 h after infection; **p < 0.01.
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44. Discussion
To date, ZIKV infection has been associated to neurological
disorders such as congenital microcephaly in newborns and
Guillain-Barre syndrome (GBS), myelopathy and encephalitis in
adults [8]. ZIKV is characterized by neurotropism and neuro-
virulence; in fact, in many registered cases ZIKV was identiﬁed
mainly in cerebrospinal ﬂuid (CSF) both in newborns and adults
Fig. 2. ZIKV induces the increase of IL-1b and inﬂammasome activation. U87-MG cells were infected with ZIKV for 48 and 72 h. (a) Expression of IL-1b, (b) NLRP3 and (c) CASP1
(the main components of inﬂammasome) were measured after incubation periods. Analyses were performed using real time quantitative polymerase chain reaction (PCR), and
results were normalized to ACTB expression. Expression of untreated cells was normalized to 1. Expression data for the three independent experiments are reported as 2�DDCt
average ± SD, in which DDCt ¼ DCt_stimulated HCeDCt_RHC. Data analyses were performed with one-way ANOVA and Bonferroni correction comparing NT (not treated) cells with
the other experimental conditions; *p < 0.05. (c) Representative Western blots showing expression of pro-IL-1b, IL-1b, and HSP-90, the latter used as the reference protein, NT ¼ not
transfected cells. Then quantiﬁcation of (d) pro-IL-1b and (e) IL-1b increase normalized to HSP-90 optical density in U87-MG cells. Results are representative of three independent
experiments. Data analyses were performed with one-way ANOVA and Bonferroni correction comparing NT cells with the other experimental conditions; *p < 0.05.
Fig. 3. ZIKV induces oxidative stress increasing SOD2 and HemeOX genes expression. U87-MG cells were infected with ZIKV for 48 and 72 h. Oxidative stress was assessed
evaluating the expression of (a) SOD2 and (b) HemeOX genes. Analyses were performed using real time quantitative polymerase chain reaction (PCR), and results normalized to ACTB
expression. Expression of untreated cells was normalized to 1. Expression data for the three independent experiments are reported as 2�DDCt average ± SD, in which
DDCt ¼ DCt_stimulated HCeDCt_RHC. Data analyses were performed with one-way ANOVA and Bonferroni correction comparing NT (not treated) cells with the other experimental
conditions; *p < 0.05.
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5[9,11,16,28]. Several studies identiﬁed microglial nodules, gliosis,
neuronal and glial cells cellular degeneration and necrosis in brain
of ZIKV þ infants [11,13], suggesting that neuroinﬂammation and
microglial activation could have a role in these neurological
disorders.
To date, little information is available about neuroinﬂammation
and ZIKV neurological disorders; so we decided to study ZIKV
infection in glial cell (U87-MG), the cells mainly involved in the
inﬂammatory response and immune surveillance in CNS.
Firstly, we investigated if ZIKV is able to infect U87-MG cells: we
found that ZIKV is able to infect U87-MG and replicate in this cell
line (Fig. 1). These results are in accordance with a study by Now-
akowski and collaborators, that identiﬁed AXL, a possible candidate
ZIKV entry receptor, highly expressed in glial cells [14].
Then, we studied how U87-MG responded to ZIKV infection in
terms of inﬂammation, evaluating IL-1b gene expression and pro-
tein production as well as gene expression of the two main com-
ponents of inﬂammasome, NLRP-3 and CASP-1. We found that ZIKV
infection, mainly after 48 h, induces the increase of IL-1b, NLRP-3
and CASP-1 expression; these ﬁndings have been conﬁrmed by the
signiﬁcant increase of IL-1b protein levels and by unchanged pro-
IL-1b protein levels (Fig. 2). Therefore, ZIKV in U87-MG induces
inﬂammation connected to NLRP3 inﬂammasome that, through the
activation of pro-caspase-1, induces proteolysis of pro-IL-1b and
release of mature IL-1b. Several studies observed NLRP3 inﬂam-
masome activation and IL-1b release after infection by ﬂavivirus,
such as Dengue, West Nile, Yellow Fever and Japanese encephalitis
viruses [23e25]. In most case, inﬂammasome and caspase-1 acti-
vation led to pyroptosis cell death, which might contribute to the
ampliﬁcation of inﬂammatory response [21,23]. Inﬂammasome
NLRP3 is very sensitive to oxidative stress possibly generated by
ﬂavivirus infection; in fact, Chen W. and collaborators observed
that HCV RNA, in human myeloid cells, activates the NLRP3
inﬂammasome in a ROS-dependent manner, conﬁrming the close
relationship between oxidative stress and inﬂammasome activa-
tion [20].
In agreement with these evidences, we observed an increased
gene expression for two important antioxidant enzymes commonly
used to assess oxidative stress, the superoxide dismutase 2 (SOD2)
and heme oxygenase (HemeOX), mainly after 48 h of ZIKV infection
(Fig. 3). SOD2 is the major antioxidant enzyme localized within
mitochondria and it efﬁciently eliminates the superoxide generated
from molecular oxygen in the respiratory chain. In addition to
having a role in oxidative stress, SOD2 expression in CNS is often
associated with neuroinﬂammation [29,30]. Instead, HemeOX is a
major endoplasmic reticulum associated heme protein, and it is
known to have an important antioxidant role in tissue injury,
attenuating the overall production of ROS in disease states. In
addition,HemeOX overexpressionmay be a trigger of mitochondrial
dysfunction characteristic of many neurodegenerative disorders
[31,32]. So, our results show that ZIKV infection in U87-MG is able
to increase the oxidative stress that could be the cause of NLRP3
inﬂammasome activation. Oxidative stress has been shown
following many triggers including viral infection. This stress may
contribute both to the activation of the inﬂammatory response and
to viral pathogenesis, regulation of viral replication andmodulation
of cellular response [33]. Moreover, Liao and collaborators observed
that oxidative stress of glial cells infected with JEV is implicated in
inﬂammation and also in cell death [34].
Finally we found a decrease of U87-MG cell viability, after both
48 h and 72 h of ZIKV infection (Fig. 4). Therefore, our results
indicate that U87-MG cells are susceptible to the ZIKV infection; the
virus is able to successfully replicate in infected cells causing
oxidative stress, NLRP3 inﬂammasome activation and subsequent
release of IL-1b mature. This process culminates in cell death that
could hypothesize as occurring through pyroptosis, a caspase-1
dependent programmed cell death that involves NLRP3 inﬂam-
masome and IL-1b [35].
So, considering the central role of neuroinﬂammation in
neurological disorders, it is important to comprehend every aspect
of this mechanism in order to better understand the pathogenesis
of ZIKV infection. Unfortunately to date, the pathogenesis of ZIKV is
partly unknown, but the balance between stress, inﬂammation and
cellular responses is the basis of the control of viral replication, and
then the development of the disease itself. Hence, the knowledge of
these molecular mechanisms is essential also to identify novel
strategies to ﬁght the virus as well as to rescue the cell death in
neuronal cells.
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